Pulmonary Medicine

Episodes 1-16 of 74

• 

  RestartResume

  Pulmonary Hypertension: Comorbidities With PAH and Group 2 PH 

  RestartResume

  Pulmonary Hypertension: Comorbidities With PAH and Group 2 PH 

  CME/CE Live Broadcast

  Pulmonary Hypertension: Comorbidities With PAH and Group 2 PH 

  October 15, 2024

  02:00 PM - 03:00 PM EDT

  1.00 credit Learn more

• 

  RestartResume

  Risk Stratification Refinements with inclusion of Hemodynamic variables at follow up in patients with PH  

  RestartResume

  Risk Stratification Refinements with inclusion of Hemodynamic variables at follow up in patients with PH  

  MinuteCE®

  Risk Stratification Refinements with inclusion of Hemodynamic variables at follow up in patients with PH  

  1.00 program credit

  • 

    

    Richard N. Channick, MD

  1.00 program credit

• 

  MinuteCE®

  The Next Generation of Treatment for Patients With PH

  1.00 credit 4 episodes

  • 

    

    Richard N. Channick, MD

  • 

    

    Vallerie V. McLaughlin, MD

  • 

    

    Ioana Preston, MD

  1.00 credit 4 episodes

• 

  RestartResume

  Are the current guidelines current?

  RestartResume

  Are the current guidelines current?

  MinuteCE®

  Are the current guidelines current?

  1.00 program credit

  • 

    

    Vallerie V. McLaughlin, MD

  1.00 program credit

• 

  RestartResume

  Strategies to Implement Risk Stratification in the PH Clinic

  RestartResume

  Strategies to Implement Risk Stratification in the PH Clinic

  MinuteCE®

  Strategies to Implement Risk Stratification in the PH Clinic

  1.00 program credit

  • 

    

    Vallerie V. McLaughlin, MD

  • 

    

    Ioana Preston, MD

  1.00 program credit

• 

  RestartResume

  Risk and How Risk Directs Treatment: Challenges and Barriers to Risk Stratification

  RestartResume

  Risk and How Risk Directs Treatment: Challenges and Barriers to Risk Stratification

  MinuteCE®

  Risk and How Risk Directs Treatment: Challenges and Barriers to Risk Stratification

  1.00 program credit

  • 

    

    Ioana Preston, MD

  1.00 program credit

• 

  RestartResume

  Vasoreactivity in Pulmonary Hypertension

  RestartResume

  Vasoreactivity in Pulmonary Hypertension

  MinuteCE®

  Vasoreactivity in Pulmonary Hypertension

  1.50 program credits

  • 

    

    Kelly Chin, MD, MSCA

  1.50 program credits

• 

  RestartResume

  Update in Pediatric Pulmonary Hypertension

  RestartResume

  Update in Pediatric Pulmonary Hypertension

  MinuteCE®

  Update in Pediatric Pulmonary Hypertension

  1.50 program credits

  • 

    

    Richard Krasuski, MD

  1.50 program credits

• 

  RestartResume

  The Promise of Sotatercept in PAH

  RestartResume

  The Promise of Sotatercept in PAH

  MinuteCE®

  The Promise of Sotatercept in PAH

  1.50 program credits

  • 

    

    Ioana Preston, MD

  1.50 program credits

• 

  RestartResume

  Risk stratification refinements with inclusion of hemodynamic variables at follow-up in patients with pulmonary arterial hypertension

  RestartResume

  Risk stratification refinements with inclusion of hemodynamic variables at follow-up in patients with pulmonary arterial hypertension

  MinuteCE®

  Risk stratification refinements with inclusion of hemodynamic variables at follow-up in patients with pulmonary arterial hypertension

  1.50 program credits

  • 

    

    Vallerie V. McLaughlin, MD

  1.50 program credits

• 

  MinuteCE®

  Integrating Evidence for Improved Outcomes in PH

  1.50 credits 6 episodes

  • 

    

    Richard N. Channick, MD

  • 

    

    Vallerie V. McLaughlin, MD

  • 

    

    Ioana Preston, MD

  • 

    

    Kelly Chin, MD, MSCA

  • 

    

    Richard Krasuski, MD

  1.50 credits 6 episodes

• 

  RestartResume

  Macitentan Update: Impact on Management of Pulmonary Hypertension

  RestartResume

  Macitentan Update: Impact on Management of Pulmonary Hypertension

  MinuteCE®

  Macitentan Update: Impact on Management of Pulmonary Hypertension

  1.50 program credits

  • 

    

    Richard N. Channick, MD

  1.50 program credits

• 

  RestartResume

  Updates on Pulmonary Hypertension Clinical Trials

  RestartResume

  Updates on Pulmonary Hypertension Clinical Trials

  MinuteCE®

  Updates on Pulmonary Hypertension Clinical Trials

  1.50 program credits

  • 

    

    Vallerie V. McLaughlin, MD

  1.50 program credits

• 

  RestartResume

  Finding the Patient With PH Among Us: How We Optimize Treatment Based on Patient Type

  RestartResume

  Finding the Patient With PH Among Us: How We Optimize Treatment Based on Patient Type

  MinuteCE®

  Finding the Patient With PH Among Us: How We Optimize Treatment Based on Patient Type

  1.00 program credit

  • 

    

    Richard N. Channick, MD

  1.00 program credit

• 

  RestartResume

  Practical Implications of New Treatments in Clinical Practice

  RestartResume

  Practical Implications of New Treatments in Clinical Practice

  MinuteCE®

  Practical Implications of New Treatments in Clinical Practice

  1.00 program credit

  • 

    

    Jean M. Elwing, MD

  • 

    

    Richard N. Channick, MD

  • 

    

    Victor Moles, MD

  1.00 program credit

• 

  MinuteCE®

  The Next Generation of Risk Stratification in Patients With PH

  1.00 credit 4 episodes

  • 

    

    Jean M. Elwing, MD

  • 

    

    Richard N. Channick, MD

  • 

    

    Victor Moles, MD

  1.00 credit 4 episodes